22/18. Ivosidenib- (TIBSOVO)- (July 2018)- to treat relapsed or refractory leukemia
Drug Name:22/18. Ivosidenib- (TIBSOVO)- (July 2018)- to treat relapsed or refractory leukemia
List Of Brands:
Indication Type Description:
22/18. Ivosidenib- (TIBSOVO)- (July 2018)- to treat relapsed or refractory leukemia
List Of Brands:
Indication Type Description:
Free Mobile App
Designed By Quadwave
Home
About Us
FAQs
Feedback
Contact Us
Site Map
Copyright (c) inPharmation 2014
About Us
FAQs
Feedback
Contact Us
Site Map
Copyright (c) inPharmation 2014
Disclaimer: Every effort has been made to ensure that the information provided in
this Database is authentic and accurate. Commissions or omissions in the database,
if any, are purely inadvertent and the site owner shall not accept any liability
whatsoever for any adverse consequences of any nature arising to any individual
or third party, as a result of usage of this information.